| pubmed-article:16001643 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0850666 | lld:lifeskim |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0041942 | lld:lifeskim |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0006153 | lld:lifeskim |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:16001643 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:16001643 | pubmed:issue | 64 | lld:pubmed |
| pubmed-article:16001643 | pubmed:dateCreated | 2005-7-8 | lld:pubmed |
| pubmed-article:16001643 | pubmed:abstractText | Results of 13C urea breath test (UBT), a noninvasive test for detecting active H. pylori infection, have been regarded also numerically for a possible predictive value on bacterial load and entity of mucosal inflammation. In the present study we wished to determine whether there is a particular value of Delta Over Baseline (DOB) result which could predict resistance to anti-H. pylori therapy. | lld:pubmed |
| pubmed-article:16001643 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16001643 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16001643 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16001643 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:GasbarriniAnt... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:ArmuzziAlessa... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:SantarelliLuc... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:CremoniniFili... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:ZoccoMaria... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:GabrielliMaur... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:BartolozziFra... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:NistaEnrico... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:CandelliMarce... | lld:pubmed |
| pubmed-article:16001643 | pubmed:author | pubmed-author:SantoliquidoA... | lld:pubmed |
| pubmed-article:16001643 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16001643 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:16001643 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16001643 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16001643 | pubmed:pagination | 1119-21 | lld:pubmed |
| pubmed-article:16001643 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:meshHeading | pubmed-meshheading:16001643... | lld:pubmed |
| pubmed-article:16001643 | pubmed:articleTitle | Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? | lld:pubmed |
| pubmed-article:16001643 | pubmed:affiliation | Istituto di Medicina Interna e Geriatria, Universita Cattolica del Sacro Cuore, Policlinico Gemelli, Roma, Italia. | lld:pubmed |
| pubmed-article:16001643 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16001643 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16001643 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
